Label: LIDOCAINE DRY- lidocaine spray
- NDC Code(s): 69842-543-04
- Packager: CVS
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
- Marketing Status: OTC monograph not final
DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
Drug Label Information
Updated August 4, 2021
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Active Ingredient
- Topical Anesthetic
- Use
- Warnings
- Do not use
-
When using this product
- Use only as directed. Read and follow all directions and warnings on this label
- do not allow contact with the eyes and mucous membranes
- avoid spraying on face
- avoid inhalation of spray
- do not bandage or apply local heatl(such as heating pads) or a medicated patch to area of use
- do not use at the same time as other topical analgesics
- Stop use and as a doctor if
- Extremely Flammable
- If pregnant or breast-feeding
- Keep out of reach of children
- Directions
- Inactive Ingredients
- Principal Display Panel
-
INGREDIENTS AND APPEARANCE
LIDOCAINE DRY
lidocaine sprayProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:69842-543 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength LIDOCAINE (UNII: 98PI200987) (LIDOCAINE - UNII:98PI200987) LIDOCAINE 4 g in 100 mL Inactive Ingredients Ingredient Name Strength PROPYLENE GLYCOL (UNII: 6DC9Q167V3) MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U) ALCOHOL (UNII: 3K9958V90M) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:69842-543-04 113 mL in 1 CAN; Type 0: Not a Combination Product 07/22/2021 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC monograph not final part348 07/22/2021 Labeler - CVS (062312574)